Jpmorgan Chase & CO Ampio Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.16 - $0.47 $14,620 - $42,948	-91,380 Reduced 99.84%	147 $0
Q1 2022 May 11, 2022	BUY	$0.42 - $0.62 $8,171 - $12,063	19,457 Added 27.0%	91,527 $43,000
Q4 2021 Feb 10, 2022	SELL	$0.56 - $1.71 $5,201 - $15,884	-9,289 Reduced 11.42%	72,070 $41,000
Q3 2021 Nov 12, 2021	BUY	$1.21 - $1.8 $98,444 - $146,446	81,359 New	81,359 $134,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.